BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211115
DTEND;VALUE=DATE:20211117
DTSTAMP:20260603T162942
CREATED:20210322T110652Z
LAST-MODIFIED:20210322T110728Z
UID:111795-1636934400-1637107199@www.afssi.fr
SUMMARY:5ème édition Immunotherapies & Innovations for Infectious Diseases Congress 2021 (I4ID21)
DESCRIPTION:THÈMES ABORDÉS\n\nNouvelle génération de conception de vaccins\n Approches antibactériennes : nouvelles tendances et défis (alternatives aux antibiotiques)\nNouveaux outils pour accélérer la détection\, la surveillance et le diagnostic (biomarqueurs\, tests compagnons\, conception de bases d’IA )\nPrédiction des foyers futurs : de l’animal à l’homme (épidémiologie\, surveillance de la transmission des agents pathogènes\, mise à jour COVID-19)\nImmunité muqueuse et thérapeutique basée sur le microbiote\n\nRetrouvez le programme \nINSCRIPTIONS\nLes membres AFSSI bénéficient : \n\nD’une réduction de 20% sur le tarif d’inscription (code : AFSSI20)\n\n  \nVous êtes intéressé par cet événement ? \nInscrivez-vous
URL:https://www.afssi.fr/event/i4id2021/
LOCATION:Lyon\, France
CATEGORIES:Evénement filière,Evénement partenaire
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2021/03/banner-event-I4ID2021.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20211116T170000
DTEND;TZID=Europe/Paris:20211116T170000
DTSTAMP:20260603T162942
CREATED:20211015T072840Z
LAST-MODIFIED:20211015T073801Z
UID:141974-1637082000-1637082000@www.afssi.fr
SUMMARY:Oncodesign Webinar - How Rodent and NHP Models Support COVID-19 Treatment Development
DESCRIPTION:Webinar topics :\nPreclinical validation of an extended portfolio of prophylactic and therapeutic options against SARS-CoV-2-induced pathologies remains a major challenge for the scientific and medical community. In this context\, the high value of several animal models of SARS-CoV-2 infection has been demonstrated to screen a variety of products\, such as vaccines\, biologics or small molecules (repurposed drugs and new chemical entities). Still\, choosing the right animal model might be challenging\, based on various modes of action and/or timing of action of the tested molecules. \nIn this webinar\, our guest presenters will discuss several case studies to illustrate the features of rodent (golden Syrian hamster\, human AC2-expressing mice) and nonhuman primate (NHP) models\, which provide different pathology settings (moderate vs. severe COVID-19). These examples will help the attendees in their decision process regarding valid COVID-19 model selection. \nThere are two main rodent models available to study the effects of potential COVID-19 treatments. SARS-CoV-2 infection of hamsters results in a moderate COVID-19 pathology (transient body weight loss\, moderate lung inflammation) with rapid development of a protective immune response (cytokine release\, neutralizing antibody response). Lethal models of SARS-CoV-2 infection\, linked to severe cytokine-release syndrome\, can be obtained using human ACE2-transgenic mouse models. \nIn the NHP SARS-CoV-2 infection\, a large number of clinical\, biological\, virological and immunological parameters can be monitored in a close-to-human setting. In all of these experimental models\, prophylactic and therapeutic strategies can be evaluated\, depending on each product-specific mode of action. \nRegister for this webinar to learn how to select the most appropriate COVID-19 animal model for preclinical studies. \nProgram :\n\nRoger Le Grand | Director of CEA / IDMIT\nNicolas Legrand | Director of Oncodesign’s study unit and vivo laboratory\n\nQuestions / Answers\nInscription\n  \n#covid19 #sarsCov2 #VivoModel #preclinical #rodent #animalmodels #NonHumanPrimate\n#Oncodesign #VectorOfInnovation #IDMIT #CEA \n 
URL:https://www.afssi.fr/event/how-rodent-and-nhp-models-support-covid-19-treatment-development/
LOCATION:Format digital
CATEGORIES:Evénement partenaire
ATTACH;FMTTYPE=image/png:https://www.afssi.fr/wp-content/uploads/2021/10/banner-event-webinar-Oncodesign-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20211124T100000
DTEND;TZID=Europe/Paris:20211124T123000
DTSTAMP:20260603T162942
CREATED:20211115T113539Z
LAST-MODIFIED:20211122T113630Z
UID:145370-1637748000-1637757000@www.afssi.fr
SUMMARY:Webinaire Adebiotech - Rôle des microbiotes dans les fonctions immunitaires : Stratégies de prévention et de traitement
DESCRIPTION:Au programme de ce webinaire :\n\nJoël DORÉ\, MetaGenoPolis INRAe\nFranck CARBONNEL\, CHU de Bicêtre – APHP\nMaarten VAN-DE-GUCHTE\, Micalis INRAe15\nMarc FEUILLOLEY\, Université de Rouen\nPascale BIANCHI\, Pierre Fabre Dermo-Cosmétique équipe Recherche pharmaco-Clinique\nGeneviève HÉRY-ARNAUD\, CHU Brest\, INSERM\n\nQuestions/Réponses\nInscription\n 
URL:https://www.afssi.fr/event/webinaire-adebiotech-role-des-microbiotes-dans-les-fonctions-immunitaires-strategies-de-prevention-et-de-traitement/
LOCATION:Format digital
CATEGORIES:Evénement partenaire
ATTACH;FMTTYPE=image/png:https://www.afssi.fr/wp-content/uploads/2021/11/banner-event-webinar-adebiotech.png
END:VEVENT
END:VCALENDAR